Literature DB >> 27566062

FosB and ΔFosB expression in brain regions containing differentially susceptible dopamine neurons following acute neurotoxicant exposure.

Joseph R Patterson1, Elizabeth J Kim2, John L Goudreau3, Keith J Lookingland4.   

Abstract

Parkinson disease (PD) is characterized by progressive neuronal degeneration, in particular nigrostriatal dopamine (NSDA) neurons and consequent deficits in movement. In mice and non-human primates, NSDA neurons preferentially degenerate following exposure to the neurotoxicant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Tuberoinfundibular (TI) DA neurons, in contrast, appear to be unaffected in PD and recover following acute MPTP exposure-induced injury (Behrouz et al., 2007; Benskey et al., 2012). The recovery of the TIDA neurons is dependent on de novo protein synthesis and positively correlated with an increase in parkin mRNA and protein expression (Benskey et al., 2012, 2015). Inhibition of parkin upregulation renders TIDA neurons susceptible to degeneration following MPTP exposure. In addition to parkin, other potentially protective proteins are likely to be differentially regulated in TIDA and NSDA neurons following neurotoxicant exposure. The regulation of potential transcription factors for parkin and other neuroprotective pathway genes are of interest since they may provide novel targets for PD disease modifying therapies. As such, we sought to determine if there are time-dependent differences in the expression of AP-1 transcription factors c-Fos, c-Jun, FosB, ΔFosB and JunD in TIDA and NSDA neurons of mice following acute MPTP exposure. We observed that both FosB and ΔFosB expression increase in brain regions containing TIDA, but not NSDA neurons. Furthermore, the nuclear and long-term expression of ΔFosB is consistent with its role as a transcription factor that may influence parkin transcription, which may underlie the unique ability of TIDA neurons to recovery from an injury that leads NSDA neurons to degeneration.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Nigrostriatal DA neurons; Parkin; Parkinson disease; Tuberoinfundibular DA neurons; ΔFosB

Year:  2016        PMID: 27566062      PMCID: PMC5035640          DOI: 10.1016/j.brainres.2016.08.030

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  50 in total

1.  PROMO: detection of known transcription regulatory elements using species-tailored searches.

Authors:  Xavier Messeguer; Ruth Escudero; Domènec Farré; Oscar Núñez; Javier Martínez; M Mar Albà
Journal:  Bioinformatics       Date:  2002-02       Impact factor: 6.937

Review 2.  The functional anatomy of basal ganglia disorders.

Authors:  R L Albin; A B Young; J B Penney
Journal:  Trends Neurosci       Date:  1989-10       Impact factor: 13.837

3.  Rapid ATP loss caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mouse brain.

Authors:  P Chan; L E DeLanney; I Irwin; J W Langston; D Di Monte
Journal:  J Neurochem       Date:  1991-07       Impact factor: 5.372

4.  Subcellular compartmentalization of 1-methyl-4-phenylpyridinium with catecholamines in adrenal medullary chromaffin vesicles may explain the lack of toxicity to adrenal chromaffin cells.

Authors:  J F Reinhard; E J Diliberto; O H Viveros; A J Daniels
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

Review 5.  Modulation of striatal projection systems by dopamine.

Authors:  Charles R Gerfen; D James Surmeier
Journal:  Annu Rev Neurosci       Date:  2011       Impact factor: 12.449

6.  Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine in mice.

Authors:  R E Heikkila; A Hess; R C Duvoisin
Journal:  Science       Date:  1984-06-29       Impact factor: 47.728

7.  Activation of p38 MAPK in the substantia nigra leads to nuclear translocation of NF-kappaB in MPTP-treated mice: implication in Parkinson's disease.

Authors:  S Karunakaran; V Ravindranath
Journal:  J Neurochem       Date:  2009-05-11       Impact factor: 5.372

8.  Unique responses to mitochondrial complex I inhibition in tuberoinfundibular dopamine neurons may impart resistance to toxic insult.

Authors:  B Behrouz; R E Drolet; Z A Sayed; K J Lookingland; J L Goudreau
Journal:  Neuroscience       Date:  2007-06-20       Impact factor: 3.590

9.  Sustained resistance to acute MPTP toxicity by hypothalamic dopamine neurons following chronic neurotoxicant exposure is associated with sustained up-regulation of parkin protein.

Authors:  Matthew Benskey; Ki Yong Lee; Kevin Parikh; Keith J Lookingland; John L Goudreau
Journal:  Neurotoxicology       Date:  2013-05-01       Impact factor: 4.294

Review 10.  Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update.

Authors:  Karen Nuytemans; Jessie Theuns; Marc Cruts; Christine Van Broeckhoven
Journal:  Hum Mutat       Date:  2010-07       Impact factor: 4.878

View more
  3 in total

1.  Sex differences in memory and intracellular signaling after methamphetamine binge treatment.

Authors:  Anthony Klambatsen; Stephanie K Nygard; Anna J Chang; Vanya Quinones; Shirzad Jenab
Journal:  Brain Res       Date:  2019-01-07       Impact factor: 3.252

2.  CDK5-mediated phosphorylation of XBP1s contributes to its nuclear translocation and activation in MPP+-induced Parkinson's disease model.

Authors:  Feng-Juan Jiao; Qing-Zhi Wang; Pei Zhang; Jian-Guo Yan; Zheng Zhang; Feng He; Qian Zhang; Ze-Xi Lv; Xiang Peng; Hong-Wei Cai; Bo Tian
Journal:  Sci Rep       Date:  2017-07-17       Impact factor: 4.379

3.  RNA-Seq analysis of knocking out the neuroprotective proton-sensitive GPR68 on basal and acute ischemia-induced transcriptome changes and signaling in mouse brain.

Authors:  Guokun Zhou; Tao Wang; Xiang-Ming Zha
Journal:  FASEB J       Date:  2021-04       Impact factor: 5.834

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.